Lv5
1280 积分 2022-10-06 加入
Definition and diagnostic criteria of clinical obesity
3天前
已完结
Evolution of peptide YY analogs for the management of type 2 diabetes and obesity
18天前
已完结
Effects of site-directed mutagenesis of GLP-1 and glucagon receptors on signal transduction activated by dual and triple agonists
19天前
已完结
Machine learning designs new GCGR/GLP-1R dual agonists with enhanced biological potency
19天前
已完结
Targeting the incretin system in obesity and type 2 diabetes mellitus
19天前
已完结
A randomized phase 2b trial examined the effects of the glucagon-like peptide-1 and glucagon receptor agonist cotadutide on kidney outcomes in patients with diabetic kidney disease
24天前
已完结
Solid-phase peptide syntheses
26天前
已关闭
Structural analysis of the dual agonism at GLP-1R and GCGR
26天前
已完结
Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis
26天前
已完结
皖公网安备34019202002308
